SETTLEMENT AGREEMENTLicense Agreement • October 14th, 2015 • Cipher Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
This Settlement Agreement (including Exhibits A through C, the “Agreement”) is made and entered into this 2nd day of October, 2015 (the “Effective Date”), by and between, on the one hand, Cipher Pharmaceuticals Inc., Galephar Pharmaceutical Research, Inc., Ranbaxy Inc., and Ranbaxy Pharmaceuticals, Inc. (collectively, “Plaintiffs”), and on the other hand, Actavis Laboratories Fl, Inc., Andrx Corp., Actavis, Inc. and Actavis Pharma, Inc. (collectively, “Actavis”) (collectively, the “Parties,” or each separately, a “Party”).
